CRESCENT BIOPHARMA, INC. (CBIO) Pre-Tax Margin
- 2015-06-30: Pre-Tax Margin 51.86%.
- 2014-06-30: Pre-Tax Margin 53.69%.
- 2013-09-30: Pre-Tax Margin -7039.78%.
- 2013-06-30: Pre-Tax Margin -6349.75%.
Complete source-backed pre-tax margin history.
- Available history
- 2013-06-30 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2015-06-30 | 51.86% |
| 2014-06-30 | 53.69% |
| 2013-09-30 | -7039.78% |
| 2013-06-30 | -6349.75% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -1401.16% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |